GBS drug trial pulled before it even started
Disease control
Terminated
This study aimed to test the safety and effectiveness of efgartigimod in people with Guillain-Barre syndrome (GBS), a rare nerve disorder causing weakness. Participants would have received the drug alongside standard care and undergone blood tests and surveys. However, the trial …
Phase: PHASE2 • Sponsor: Chafic Karam • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC